ArticleEMBO molecular medicine2016
Chronic miR-29 antagonism promotes favorable plaque remodeling in atherosclerotic mice.
Victoria Ulrich et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
41 papers cite it
this paperpooled itcites it